NASA Awards Redwire $4 Million In Additional Funding to Support Trailblazing Drug Development in Microgravity

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that NASA has awarded the company an additional $4 million to support new drug development investigations on the International Space Station (ISS) using Redwire’s Pharmaceutical In-space Laboratory (PIL-BOX) technology. This additional funding expands an existing task order under a $25 million, five-year indefinite-delivery/indefinite-quantity contract through NASA’s In Space Production Applications (InSPA) program.

“The space and pharmaceutical industries are coming together in a way that will transform both fields,” said Mike Gold, President of Redwire’s Space business segment. “NASA and the InSPA program are playing a critical role by acting as a catalyst for revolutionary new public and private sector capabilities, and we’re proud and grateful that they have selected Redwire to implement this work tackling diseases ranging from cancer to osteoporosis and obesity. By going to space, together with our NASA partners, we can improve life on Earth.”

With 43 units flown, PIL-BOX has contributed to the growth of high‑quality crystals that could transform how lifesaving medicines are developed. Redwire recently supported a cancer therapy investigation led by Aspera Biomedicines (Aspera) that launched aboard the SpaceX Crew-12 mission to the ISS. Aspera and Redwire are using PIL‑BOX to advance development of Rebecsinib, an ADAR1 inhibitor. Results from the investigation have the potential to enable new drug formulations that will provide broader cancer treatment options.

By supporting partners such as Aspera, Bristol Myers Squibb, Eli Lilly and Company, ExesaLibero Pharma, Purdue University, and Butler University, Redwire is helping drive a new era of biotechnology where microgravity unlocks insights that can improve treatments for some of the world’s most challenging diseases.

About Redwire

Redwire Corporation (NYSE:RDW) is an integrated space and defense tech company focused on advanced technologies. We are building the future of aerospace infrastructure, autonomous systems, and multi-domain operations leveraging digital engineering and AI automation. Redwire’s approximately 1,400 employees located throughout North America and Europe are committed to delivering innovative space and airborne platforms transforming the future of multi-domain operations. For more information, please visit RDW.com.